Metabolic dysfunction-associated steatotic liver disease (MASLD) can be a possible predictive factor of incident CKD: NAGALA cohort study

• Yuriko Ono,

  Roles Writing – original draft

  Affiliation Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

  ⨯
• Kimiko Sakai,

  Roles Data curation

  Affiliation Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

  ⨯
• Takuro Okamura,

  Roles Supervision

  Affiliation Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

  ⨯
• Hiroshi Okada,

  Roles Supervision

  Affiliation Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

  ⨯
• Akihiro Obora,

  Roles Supervision

  Affiliation Department of Gastroenterology, Asahi University Hospital, Gifu, Japan

  ⨯
• Takao Kojima,

  Roles Supervision

  Affiliation Department of Gastroenterology, Asahi University Hospital, Gifu, Japan

  ⨯
• Masahide Hamaguchi ,

  Roles Supervision

  * E-mail: mhama@koto.kpu-m.ac.jp

  Affiliation Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

  https://orcid.org/0000-0002-8651-4445

  ⨯
• Michiaki Fukui

  Roles Supervision

  Affiliation Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

  ⨯